Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
6.01
+0.10 (1.78%)
Nov 28, 2025, 4:00 PM EST - Market closed
Predictive Oncology Market Cap
Predictive Oncology has a market cap or net worth of $20.38 million as of November 28, 2025. Its market cap has increased by 284.49% in one year.
Market Cap
20.38M
Enterprise Value
21.73M
1-Year Change
284.49%
Ranking
Category
Stock Price
$6.01
Market Cap Chart
Since August 31, 2015, Predictive Oncology's market cap has increased from $13.20M to $20.38M, an increase of 54.38%. That is a compound annual growth rate of 4.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 20.00M | 263.64% |
| Dec 31, 2024 | 5.50M | -58.96% |
| Dec 29, 2023 | 13.40M | -44.40% |
| Dec 30, 2022 | 24.10M | -61.38% |
| Dec 31, 2021 | 62.40M | 383.72% |
| Dec 31, 2020 | 12.90M | 27.72% |
| Dec 31, 2019 | 10.10M | 16.09% |
| Dec 31, 2018 | 8.70M | 38.10% |
| Dec 29, 2017 | 6.30M | -33.68% |
| Dec 30, 2016 | 9.50M | -37.50% |
| Dec 31, 2015 | 15.20M | 15.15% |
| Aug 31, 2015 | 13.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |